http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006070349-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61fea27a8232dcd52e1fcd913236eefe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3093a4f2d4842f695e0a61ab915dc4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a947c5b565bf9b9919794f03db37eca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_608b4d92a404287e4d75a992162f65b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4146c8289a0f999cb69705ffe6d2090b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05b6405b4804afb47619ff15f1024f1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b808a0b0fe6578f7dce5157bab61e8c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-82
filingDate 2005-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33dc9eafffc2b84bbfefe3d644429f99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6818e1ced7ca2bcc45afa4c4de925ec1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_262c73630e3e0e52629378924f449175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_588b600c9201653984535ea6506c28f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a461ca609b5ba282f5dd1fa965ba111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7c70aac0f7fa5703d27f34cdcb02f7b
publicationDate 2006-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006070349-A3
titleOfInvention Novel process for preparing pramipexole and its optical isomeric mixture by reduction with sodium triacetoxyborohydride
abstract A novel process is provided for producing pramipexole base or its optical isomeric mixture as defined hereinabove i.e. (R,S)-2-amino-6-propyl-4,5,6,7-tetrahydrobenzothiazole avoiding the use of borane tetrahydrofuran complex and using a more convenient reducing agent like sodium triacetoxyborohydride instead. The provided process comprises reacting the starting material (S) -2,6-diamino-4,5,6,7-tetrahydrobenzothiazole or its optical isomeric mixture as defined hereinabove i.e. (R,S)-2,6-diamino-4,5,6,7-tetrahydrobenzothiazole with propionaldehyde in an organic solvent to obtain the respective enamine, which is subsequently reduced in situ, optionally without isolation, to obtain pramipexole or its optical isomeric mixture as defined hereinabove i.e. (R,S)-2-amino-6-propyl-4,5,6,7-tetrahydrobenzothiazole, and the acid addition salts thereof. The present invention also provides a process for purifying pramipexole dihydrochloride or the dihydrochloride salt of its optical isomeric mixture as defined hereinabove i.e. (R,S)-2-amino-6-propyl-4,5,6,7-tetrahydrobenzothiazole dihydrochloride by re-crystallization from a suitable solvent.
priorityDate 2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6770761-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11062302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226646551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10329721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231597917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87895210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231597598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231597593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426179733
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87895209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231597924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51731139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51731138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11521153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231597920
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447535447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231597594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22726021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452110971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453200485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16743100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228200155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11820020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226646552

Total number of triples: 56.